Zydus Life Science P/E Ratio

ZYDUSLIFE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
17.3
Moderate Valuation
Moderate - Fairly valued

Current Valuation Metrics

P/E Ratio 17.3
Current Price ₹891.55
EPS (TTM) ₹44.97
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 19.24
Historical Range 10.27 - 29.0
Percentile 40.0%

Sector Context

Sector Average 47.71
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹49.09
Sept 2025 ₹12.51
Mar 2025 ₹11.64

Key P/E Ratio Insights for Zydus Life Science

  • Trading at discount to sector average PE of 47.71

P/E Ratio Historical Trend for Zydus Life Science

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 19.84 49.09 ₹973.80 NSE Moderate
2024 15.53 45.03 ₹699.15 NSE Moderate
2023 14.3 29.38 ₹420.10 NSE Low
2022 23.58 20.24 ₹477.25 NSE Moderate
2021 10.27 46.59 ₹478.40 NSE Low
2020 14.1 18.03 ₹254.25 NSE Low
2019 29.0 12.07 ₹350.05 NSE High
2018 22.37 19.34 ₹432.55 NSE Moderate
2017 23.09 15.35 ₹354.50 NSE Moderate
2016 20.35 16.35 ₹332.70 NSE Moderate

Sector P/E Ratio Comparison

Comparing Zydus Life Science with other companies in Healthcare sector
Sector Average
47.71
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low